ici 118551 and Invasiveness, Neoplasm

ici 118551 has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, HT; Ma, QY; Zhang, D; Zhang, M1

Other Studies

1 other study(ies) available for ici 118551 and Invasiveness, Neoplasm

ArticleYear
β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
    Cancer biology & therapy, 2010, Jul-01, Volume: 10, Issue:1

    Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Humans; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Vascular Endothelial Growth Factor A

2010